Burris, H.A. (2004) Dual Kinase Inhibition in the Treatment of Breast Cancer Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib. The Oncologist, 9, 10-15. - References

Journals by Subject

Publish with us

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Burris, H.A. (2004) Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib. The Oncologist, 9, 10-15.
https://doi.org/10.1634/theoncologist.9-suppl_3-10

has been cited by the following article:

Open Access

Articles

Expectations of Patients with a Diagnosis of Breast Cancer When Meeting the Psycho-Oncologist: Beyond the Assistance of the Oncologist

David Ogez, Philippe de Timary, Martine Berlière, Leila Rokbani, Maud Colmant, Frédérique Lieutenant, Guillaume Gascard, Catherine Denoel, Aline van Maanen, Emmanuelle Zech

Open Journal of Medical Psychology Vol.3 No.5, September 17, 2014

DOI: 10.4236/ojmp.2014.35033
Open Access

Articles

Studies on Focal Adhesion Kinase in Human Breast Cancer Tissue

Kirat Kumar Ganguly, Triparna Sen, Syamsundar Mandal, Jaydip Biswas, Amitava Chatterjee

Journal of Cancer Therapy Vol.3 No.1, February 16, 2012

DOI: 10.4236/jct.2012.31002
Open Access

Articles

Investigation of Methylation Profiles of TP53, Caspase 9, Caspase 8, Caspase 3 Genes Treated with DNA Methyl Transferase Inhibitor (DNMTi) Zebularine (ZEB) and Caffeic Acid Phenethyl Ester (CAPE) on MCF-7 and MDA-MB-231 Breast Cancer Cell Lines

Onur Eroglu, Esin Guvenir Celik, Hacer Kaya, Merve Celen, Mustafa Karabicici, Elif Karacoban

Journal of Cancer Therapy Vol.10 No.1, January 23, 2019

DOI: 10.4236/jct.2019.101006
Open Access

Articles

Association between Subjective Evaluation of Skin Toxicities and Quality of Life in Patients with Lung Cancer Undergoing Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Pilot Study for Developing Skin Toxicity Assessment

Kengo Hirayama, Ya Su, Yasuyuki Ikezawa, Megumi Chiba, Kenichiro Ito, Michiko Yuki

Open Journal of Nursing Vol.9 No.12, December 18, 2019

DOI: 10.4236/ojn.2019.912089
Open Access

Articles

Abemaciclib, a Recent Novel FDA-Approved Small Molecule Inhibiting Cyclin-Dependant Kinase 4/6 for the Treatment of Metastatic Breast Cancer: A Mini-Review

Lou Anna Voli, Janat A. Mamyrbékova, Jean-Pierre Bazureau

Open Journal of Medicinal Chemistry Vol.10 No.3, September 2, 2020

DOI: 10.4236/ojmc.2020.103007

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies